open notebook with handwritten numeric figures, calculator, cup of tea, wooden desk salary intelligence

NHS Pharmacist Pay: England vs Wales Bands Compared (2026)

NHS Wales advertises the same Agenda for Change pharmacist grades on slightly higher cash floors than England in 2026 — though London weighting reverses the gap in the South East.

By PharmSee Editorial Team · ·

When a hospital pharmacist in Cardiff and one in Carlisle hold the same Agenda for Change grade, do they earn the same? Not quite. A review of current NHS pharmacist vacancies suggests that NHS Wales advertises the same banded roles on slightly higher cash floors than NHS England — a gap of roughly £740 to £970 a year at the grades where the two nations can be compared directly.

The difference is small, consistent, and easy to miss, because both nations use the same Agenda for Change (AfC) band names. A "Band 8a Advanced Clinical Pharmacist" reads identically whether the post is in Swansea or Sheffield. But the cash figures attached to those bands are set through separate pay settlements, and in 2026 the Welsh scale sits marginally ahead of the English one.

How we looked at it

This comparison is built only from salaries that NHS employers chose to publish in their own job adverts. It draws on a snapshot of 200 NHS Jobs pharmacist listings captured on 29 June 2026, of which 104 carried a specific annual salary range. NHS Jobs is the one recruitment channel where pharmacist pay is disclosed on almost every posting, which makes it the most reliable public source for benchmarking.

Within that snapshot, English trusts cluster tightly on the published AfC band floors: 14 listings opened at exactly £49,387 (the Band 7 floor) and 28 at exactly £57,528 (the Band 8a floor). Six listings came from Welsh university health boards, and these consistently advertised the same nominal bands at a slightly higher number. The Welsh sample is small — six adverts — so the band-floor figures below should be read as scale values confirmed by those adverts, not as a large-sample average.

A note on scope: this is about NHS hospital and health-board pharmacist roles, where the public feed coverage is genuine. It says nothing about community pharmacy pay in Wales, which sits on a separate contractor system that is not captured here.

The grade-by-grade gap

AfC gradeEngland (advertised range)Wales (advertised range)Wales premium at floor
Band 7£49,387 – £56,515£50,129 – £57,365+£742 (≈ +1.5%)
Band 8a£57,528 – £64,750£58,379 – £65,723+£851 (≈ +1.5%)
Band 8b (single Welsh example)≈ £66,274 floor£67,583 – £78,530directional only

The pattern is the same at both ends of each band: the Welsh floor and the Welsh ceiling each sit a little above the English equivalent. At Band 8a, the most heavily advertised pharmacist grade in the snapshot, a Welsh post opens £851 higher and tops out £973 higher than its English counterpart.

The Band 8b line should be treated with caution. Only one Welsh advert at that grade appeared — a Lead Pharmacist for Haematology at Aneurin Bevan University Health Board at £67,583 to £78,530 — and the English Band 8b reading in this snapshot was thin. The direction of travel matches the lower bands, but a single advert is not enough to put a firm number on the gap.

What the adverts actually say

On the English side, the band floors are unmistakable. Royal Wolverhampton NHS Trust, Bedfordshire Hospitals NHS Foundation Trust and University Hospitals Birmingham all advertised Band 7 pharmacist roles at £49,387 to £56,515. At Band 8a, Leeds Teaching Hospitals, the Isle of Wight NHS Trust and North Cumbria Integrated Care all opened Advanced Clinical Pharmacist posts at £57,528 to £64,750.

On the Welsh side, the same grades appear a notch higher. Betsi Cadwaladr University Health Board advertised a bank Pharmacist at £50,129 to £57,365 and an Advanced Pharmacist at £58,379 to £65,723. Hywel Dda University Health Board listed two advanced pharmacist roles — a primary-care post in Ceredigion and Pembrokeshire and an Advanced Pharmacist and Teacher Practitioner in Llanelli — both at £58,379 to £65,723. Velindre Cancer Centre in Cardiff advertised an Oncology Pharmacist at £50,129 to £57,365.

Why Wales runs slightly ahead

The reason is structural rather than dramatic. Agenda for Change is a UK-wide pay framework in name, but each nation negotiates and applies its own annual uplift through its own government and partnership process. England's scales are set via NHS Employers and the Department of Health and Social Care; Wales's are set by the Welsh Government through NHS Wales Employers. Because the two settlements are reached separately and applied to slightly different starting points, the band floors can drift apart by a small margin — and in 2026 the Welsh floors land just above the English ones.

A ~1.5% gap is modest. For a pharmacist weighing a move it amounts to somewhere between £740 and £970 a year before tax at the same grade — real money, but not the kind of difference that would, on its own, justify relocating across a border.

The London caveat that flips the picture

There is one important qualification, and it works the other way. English NHS pay includes High Cost Area Supplements (HCAS) — the London weighting — which Welsh pay does not. A Band 8a post in inner London can carry an HCAS supplement of several thousand pounds on top of the base scale, comfortably overtaking the Welsh figure. So the "Wales pays a little more" finding holds at the base AfC scale and across most of England outside the South East. In London and its fringe, the English advertised salary will usually be the higher of the two once the supplement is added. Any cross-border comparison has to specify whether it is comparing base scales or London-weighted posts.

What this does and doesn't show

A few limits are worth stating plainly:

  • It is about advertised ranges, not earnings. Where a pharmacist actually lands within a band depends on prior experience and incremental progression.
  • The Welsh sample is small. Six adverts confirm the band floors but cannot speak to spread or to grades that did not appear, such as Band 6 entry roles.
  • It excludes community pharmacy. Wales runs its community pharmacy contract through a separate system, so nothing here applies to Boots, Well, supermarket or independent pharmacy pay in Wales.
  • It is a single snapshot. NHS Jobs caps each query at 200 records, and the band mix shifts from week to week. The floor figures are stable scale values; the counts are not.

For pharmacists, the practical takeaway is simple: at the same Agenda for Change grade, the headline NHS salary is marginally higher in Wales than in most of England in 2026 — but London weighting closes and usually reverses that gap in the South East.

Compare the numbers yourself

You can check current pharmacist pay against live vacancies using PharmSee's salary intelligence pages and the pharmacist salary guide, or browse the underlying NHS and community listings on PharmSee job search. The band floors quoted here are drawn directly from those live adverts, updated as new vacancies are published.


Sources: PharmSee NHS Jobs vacancy dataset, snapshot 29 June 2026 (200-listing NHS Jobs query, 104 with disclosed annual salary). Agenda for Change pay scales: NHS Employers (England) and Welsh Government / NHS Wales Employers. Salary ranges quoted are as advertised by the named NHS trusts and health boards.

Sources

  1. NHS Employers — Agenda for Change pay scales 2025/26 (England)
  2. Welsh Government — NHS staff pay

Information only — not medical advice

This article is general information about medicines and health conditions in the UK. It is not personalised medical advice and must not be used to diagnose, treat, or manage any condition. Always speak to a GPhC-registered pharmacist, your GP, NHS 111, or another qualified healthcare professional before starting, stopping, or changing any medicine — particularly if you are pregnant, breastfeeding, have kidney, liver or heart disease, or take other medicines. In an emergency call 999.

Sources are cited above for transparency; inclusion of a source does not imply endorsement of this site by the NHS, NICE, UKTIS, or the MHRA. See our Terms & Disclaimer. PharmSee accepts no liability for any loss or harm arising from reliance on this content.